홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Propranolol

HCID 4946
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
13013-17-7
표준 SMILES
CC(C)NCC(O)COc1cccc2ccccc12
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
분자식
C16H21NO2
평균 분자량
259.34 g/mol
단동위원소 질량
259.15722891

개요

Propranolol is a propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3. It has a role as an anxiolytic drug, a beta-adrenergic antagonist, a vasodilator agent, an antihypertensive agent, a xenobiotic, an anti-arrhythmia drug, an environmental contaminant and a human blood serum metabolite. It is a member of naphthalenes, a secondary amine and a propanolamine. It is functionally related to a 1-naphthol.

이름 및 식별자

우선 이름
Propranolol
IUPAC
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
영어명
Propanolol
분자식
C16H21NO2
분자량
259.34

이름 및 동의어

propranolol525-66-6Propanololbeta-PropranololBetalongEuprovasinProprasylytReducorPropanalolAnaprilinepropranololodl-propranolol
이름 더 보기
Avlocardylrac-PropanololAvlocanol208-378-0
Propranololum1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol9Y8NXQ24VQ1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol2-Propanol, 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-CHEBI:8499DTXSID6023525

데이터베이스 식별자

CAS
13013-17-7、525-66-6
PubChem CID
4946
DTXSID
DTXSID6023525
ChEMBL
CHEMBL27
ChEBI
CHEBI:8499
UNII
9Y8NXQ24VQ
EC Number
208-378-0、235-867-6
Nikkaji
J6.653B

물성

구조 계산 물성

XLogP
3
극성 표면적
41.5 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
3
회전 가능 결합 수
6
무거운 원자 수
19
형식 전하
0
복잡도
257

실험 및 물리화학적 성질

Chemical Classes · 2건

Other Uses -> Pharmaceuticals

Pharmaceutical

Drugs · 3건

Pharmaceuticals -> Used in Switzerland

Pharmaceuticals -> Antihypertensive drugs

Pharmaceuticals

LogP · 2건

3.48

3.09

Solubility0.0617 mg/L at 25 °C
Human Drugs · 5건

Antidepressants -> Beta blockers

Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Adrenergic Beta-Antagonists; Antiarrhythmics

EMA approved medicines: Human medicine

Pharmaceuticals

Antianginal medicines

Melting Point96 °C
Physical DescriptionSolid
Ionization Efficiency · 6건

Positive

3.75

2.7

Agilent XCT

Electrospray ionization

formic acid (5.3nM)

Dissociation Constants · 3건

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory.

유해성 정보

Regulatory Information · 2건

REACH registered substance: (±)-1-(isopropylamino)-3-(naphthyloxy)propan-2-ol (EC: 235-867-6)

Propranolol: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 2-Propanol, 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-: Human health tier I assessment
Hazards SummaryAllergic contact dermatitis reported in pharmaceutical workers; [Kanerva, p. 1830] See Oxprenolol.
Hazard Classes and CategoriesAcute Tox. 4 (100%)

독성 정보

Hepatotoxicity · 1건

Mild-to-moderate elevations in serum aminotransferase levels occur in less than 2% of patients on propranolol and are usually transient and asymptomatic, resolving even with continuation of therapy. Despite its widespread use, propranolol has not been convincingly linked to instances of clinically apparent liver injury; the few cases reported have generally occurred in patients who were receiving other well known hepatotoxic agents or were associated with elevations in serum enzymes only without jaundice.

Adverse Effects · 2건

화학 및 산업

약리 정보

ATC Code · 4건

C07AA05

C - Cardiovascular system

QC - Cardiovascular system

C07AA05

Protein BindingApproximately 90% of propranolol is protein bound in plasma. Other studies have reported ranges of 85-96%.
Pharmacodynamics · 1건

Propranolol is a beta-adrenergic receptor antagonist used to treat hypertension. Propranolol has a long duration of action as it is given once or twice daily depending on the indication. When patients abruptly stop taking propranolol, they may experience exacerbations of angina and myocardial infarctions.

Mechanism of Action · 1건

Propranolol is a nonselective β-adrenergic receptor antagonist. Blocking of these receptors leads to vasoconstriction, inhibition of angiogenic factors like vascular endothelial growth factor (VEGF) and basic growth factor of fibroblasts (bFGF), induction of apoptosis of endothelial cells, as well as down regulation of the renin-angiotensin-aldosterone system.

Biological Half-LifeThe elimination half-life of propranolol is approximately 8 hours. The plasma half-life of propranolol is 3 to 6 hours.
Metabolism/Metabolites · 2건

Propranolol undergoes side chain oxidation to α-naphthoxylactic acid, ring oxidation to 4’-hydroxypropranolol, or glucuronidation to propranolol glucuronide. It can also be N-desisopropylated to become N-desisopropyl propranolol. 17% of a dose undergoes glucuronidation and 42% undergoes ring oxidation.

Propranolol has known human metabolites that include (2S,3S,4S,5R)-3,4,5-Trihydroxy-6-[1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-yl]oxyoxane-2-carboxylic acid.

FDA Pharmacological Classification · 6건

9Y8NXQ24VQ

PROPRANOLOL

Mechanisms of Action [MoA] - Adrenergic beta-Antagonists

Established Pharmacologic Class [EPC] - beta-Adrenergic Blocker

관련 반응

17건
반응 기록 만들기
HRID 10485 반응식
HRID 10485생성물로
HRID 35665 반응식
HRID 35665생성물로
HRID 231910 반응식
HRID 231910생성물로
HRID 328884 반응식
HRID 328884생성물로
HRID 328886 반응식
HRID 328886생성물로
HRID 328887 반응식
HRID 328887반응물로
HRID 867506 반응식
HRID 867506반응물로
HRID 892129 반응식
HRID 892129반응물로
이전1 / 3 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

9.53

9.45

9.42

Collision Cross Section · 4건

162.5 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: APCI+; Dataset: TOXCAST; Source Identifier: DTXSID3021198]

161.5 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

162.7 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

166.22 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
163 · 163-164 °C
끓는 점
402.6 °C · 402.6°C (rough estimate)
밀도
1.028 · 1.0280 (rough estimate)
굴절률
1.55 · 1.5500 (estimate)
저장 조건
-20 °C · -20°C Freezer, Under inert atmosphere
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨)
물리적 상태
고체
산도 계수 (pKa)
13.84 · 13.84±0.20(Predicted)
색상
흰색에서 황백색까지
수용성
80.99 mg/L · 80.99mg/L(25℃)
InChI
InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
SMILES
C(NC(C)C)C(O)COC1=C2C(C=CC=C2)=CC=C1
NIST
Propranolol(525-66-6)
EPA
2 · 2-Propanol, 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)- (525-66-6)

화학적 성질

Colorless crystals.Soluble in water and alcohol; insoluble in benzene and ether.

Skin Sensitizer - An agent that can induce an allergic reaction in the skin.

Common side effects of using propranolol include bradycardia, gastrointestinal issues, abdominal pain, nausea, erectile dysfunction, and wheezing/bronchospasms. Propranolol use can also cause drowsiness, fatigue, and cold extremities. Some extreme side effects to be aware of include allergic reactions, insulin resistance, and hallucinations. Prescribers need to explain and discuss all of the side effects before giving patients a prescription for propranolol.

Toxicity SummaryIngestion of greater than 1 g of propranolol in 24 hours can potentially be lethal and lead to profound bradycardia, bradyarrhythmia, hypotension, bronchospasm.
Drug Induced Liver Injury · 6건

Benchmark Dataset for the Liver Toxicity Knowledge Base (LTKB)

propranolol

Inderal®

Beta blockers

3

less-DILI-concern drugs

Effects During Pregnancy and Lactation · 2건

◉ Summary of Use during Lactation

◈ What is propranolol?

USGS Health-Based Screening Levels for Evaluating Water-Quality · 3건

Propranolol

Pharmaceutical

Smith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP

EPA Human Health Benchmarks for Pharmaceuticals · 6건

Propranolol

0.7

3.0

The recommended dose is 10 mg to 30 mg propranolol hydrochloride three or four times daily before meals and at bedtime.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 30 mg/day, Lowest Therapeutic Dose (LTD): 0.4 mg/kg-day, and Screening Dose: 0.0001 mg/kg-day.

1-Aug-15

안전 데이터

HS 번호
2922509090
기존화학 물질
KE-23955

Propranolol is a beta-Adrenergic Blocker. The mechanism of action of propranolol is as an Adrenergic beta-Antagonist.

PROPRANOLOL

MeSH Pharmacological Classification · 4건

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Drugs used to cause dilation of the blood vessels.

Absorption, Distribution and Excretion · 4건

Patients taking doses of 40mg, 80mg, 160mg, and 320mg daily experienced Cmax values of 18±15ng/mL, 52±51ng/mL, 121±98ng/mL, and 245±110ng/mL respectively. Propranolol has a Tmax of approximately 2 hours, though this can range from 1 to 4 hours in fasting patients. Taking propranolol with food does not increase Tmax but does increase bioavailability.

91% of an oral dose of propranolol is recovered as 12 metabolites in the urine.

The volume of distribution of propranolol is approximately 4L/kg or 320L.

The clearance of propranolol is 2.7±0.03L/h/kg in infants <90 days and 3.3±0.35L/h/kg in infants >90 days. Propranolol clearance increases linearly with hepatic blood flow. Propranolol has a clearance in hypertensive adults of 810mL/min.

Tissue LocationsLiver
Cellular LocationsMembrane
Metabolite PathwaysPropranolol Action Pathway

용도 및 제조

Uses · 2건

Used as a beta-blocking agent (antihypertensive drug); [Kanerva, p. 1830]

Use (kg) in Switzerland (2009): >750

Use ClassificationPharmaceuticals

응용 분야

개요Propranolol was responsible for sensitisation of workers in drug synthesis. In one case, epichlorhydrin was used for the production of both propranolol and oxprenolol.

용도Cardiac depressant (anti-arrhythmic); anti-adrenergic (β-receptor).

상·하류 제품 정보

하류 제품

프로프라놀롤불순물프로판올 하이드로클로라이드

추가 설명

정의ChEBI: A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.